Endothelial adherens junctions at a glance

Journal of Cell Science

Volumn 126, Issue 12, 2013, Pages 2545-2549

  Dejana, Elisabetta ^a,b   Orsenigo, Fabrizio ^a  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; MEMBRANE PROTEIN; PROTEIN KINASE C EPSILON; PROTEIN PAR6; PROTEIN TYROSINE KINASE; PROTEINASE ACTIVATED RECEPTOR 3; TIGHT JUNCTION PROTEIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; BRAIN MICROCIRCULATION; CAVERNOUS HEMANGIOMA; CELL ADHESION; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CELL POLARITY; CELL STRUCTURE; ENDOTHELIUM CELL; HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TIGHT JUNCTION;

ADHERENS JUNCTIONS; ANIMALS; BRAIN; CAPILLARY PERMEABILITY; CELL ADHESION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MICROCIRCULATION;

EID: 84879860325     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.124529     Document Type: Article

References (72)

1. Abe, K. and Takeichi, M. (2008). EPLIN mediates linkage of the cadherin catenin complex to F-actin and stabilizes the circumferential actin belt. Proc. Natl. Acad. Sci. USA 105, 13-19.
2. Alcaide, P., Martinelli, R., Newton, G., Williams, M. R., Adams, A., Vincent, P. A. and Luscinskas, F. W. (2012). p120-catenin prevents neutrophil transmigration independently of Rho A inhibition by impairing Src dependent VE-cadherin phosphorylation. Am. J. Physiol. 303, C385-C395.
3. Allingham, M. J., van Buul, J. D. and Burridge, K. (2007). ICAM-1-mediated, Src-and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration. J. Immunol. 179, 4053-4064.
4. Andriopoulou, P., Navarro, P., Zanetti, A., Lampugnani, M. G. and Dejana, E. (1999). Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. Arterioscler. Thromb. Vasc. Biol. 19, 2286-2297.
5. Armulik, A., Genové, G., Maë, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K. et al. (2010). Pericytes regulate the blood-brain barrier. Nature 468, 557-561.
6. Baluk, P., Fuxe, J., Hashizume, H., Romano, T., Lashnits, E., Butz, S., Vestweber, D., Corada, M., Molendini, C., Dejana, E. et al. (2007). Functionally specialized junctions between endothelial cells of lymphatic vessels. J. Exp. Med. 204, 2349-2362.
7. Bazzoni, G. and Dejana, E. (2004). Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol. Rev. 84, 869-901.
8. Boulday, G., Blécon, A., Petit, N., Chareyre, F., Garcia, L. A., Niwa-Kawakita, M., Giovannini, M. and Tournier-Lasserve, E. (2009). Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations. Dis. Model. Mech. 2, 168-177.
9. Boulday, G., Rudini, N., Maddaluno, L., Blécon, A., Arnould, M., Gaudric, A., Chapon, F., Adams, R. H., Dejana, E. and Tournier-Lasserve, E. (2011). Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice. J. Exp. Med. 208, 1835-1847.
10. Braga, V. M. and Yap, A. S. (2005). The challenges of abundance: epithelial junctions and small GTPase signalling. Curr. Opin. Cell Biol. 17, 466-474.
11. Broermann, A., Winderlich, M., Block, H., Frye, M., Rossaint, J., Zarbock, A., Cagna, G., Linnepe, R., Schulte, D., Nottebaum, A. F. et al. (2011). Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo. J. Exp. Med. 208, 2393-2401.
12. Cain, R. J., Vanhaesebroeck, B. and Ridley, A. J. (2010). The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1. J. Cell Biol. 188, 863-876.
13. Chiasson, C. M., Wittich, K. B., Vincent, P. A., Faundez, V. and Kowalczyk, A. P. (2009). p120-catenin inhibits VE-cadherin internalization through a Rho-independent mechanism. Mol. Biol. Cell 20, 1970-1980.
14. Conway, D. and Schwartz, M. A. (2012). Lessons from the endothelial junctional mechanosensory complex. F1000 Biol. Rep. 4, 1.
15. Dejana, E., Orsenigo, F. and Lampugnani, M. G. (2008). The role of adherens junctions and VE-cadherin in the control of vascular permeability. J. Cell Sci. 121, 2115-2122.
16. Dejana, E., Tournier-Lasserve, E. and Weinstein, B. M. (2009a). The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev. Cell 16, 209-221.
17. Dejana, E., Orsenigo, F., Molendini, C., Baluk, P. and McDonald, D. M. (2009b). Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees. Cell Tissue Res. 335, 17-25.
18. Fujita, Y., Krause, G., Scheffner, M., Zechner, D., Leddy, H. E., Behrens, J., Sommer, T. and Birchmeier,W. (2002). Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat. Cell Biol. 4, 222-231.
19. Gavard, J. (2009). Breaking the VE-cadherin bonds. FEBS Lett. 583, 1-6.
20. Gavard, J. and Gutkind, J. S. (2006). VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat. Cell Biol. 8, 1223-1234.
21. Gavard, J., Patel, V. and Gutkind, J. S. (2008). Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev. Cell 14, 25-36.
22. Glading, A. J. and Ginsberg, M. H. (2010). Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling. Dis. Model. Mech. 3, 73-83.
23. Glading, A., Han, J., Stockton, R. A. and Ginsberg, M. H. (2007). KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J. Cell Biol. 179, 247-254.
24. Gloerich, M. and Bos, J. L. (2011). Regulating Rap small G-proteins in time and space. Trends Cell Biol. 21, 615-623.
25. Grinnell,K. L., Casserly, B. andHarrington, E.O. (2010). Role of protein tyrosine phosphatase SHP2 in barrier function of pulmonary endothelium. Am. J. Physiol. 298, L361-L370.
26. Grinnell, K. L., Chichger, H., Braza, J., Duong, H. and Harrington, E. O. (2012). Protection against LPSinduced pulmonary edema through the attenuation of protein tyrosine phosphatase-1B oxidation. Am. J. Respir. Cell Mol. Biol. 46, 623-632.
27. Harris, E. S. and Nelson, W. J. (2010). VE-cadherin: at the front, center, and sides of endothelial cell organization and function. Curr. Opin. Cell Biol. 22, 651-658.
28. Hartsock, A. and Nelson, W. J. (2008). Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim. Biophys. Acta 1778, 660-669. Hatanaka, K., Lanahan, A. A., Murakami, M. and Simons, M. (2012). Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2. PLoS ONE 7, e37600.
29. Hatanaka, K., Lanahan, A. A., Murakami, M. and Simons, M. (2012). Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2. PLoS ONE 7, e37600.
30. Huveneers, S., Oldenburg, J., Spanjaard, E., van der Krogt, G., Grigoriev, I., Akhmanova, A., Rehmann, H. and de Rooij, J. (2012). Vinculin associates with endothelial VE-cadherin junctions to control forcedependent remodeling. J. Cell Biol. 196, 641-652.
31. Iden, S., Rehder, D., August, B., Suzuki, A., Wolburg-Buchholz, K., Wolburg, H., Ohno, S., Behrens, J., Vestweber, D. and Ebnet, K. (2006). A distinct PAR complex associates physically with VE-cadherin in vertebrate endothelial cells. EMBO Rep. 7, 1239-1246.
32. Kleaveland, B., Zheng, X., Liu, J. J., Blum, Y., Tung, J. J., Zou, Z., Sweeney, S. M., Chen, M., Guo, L., Lu, M. M. et al. (2009). Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat. Med. 15, 169-176.
33. Kluger, M. S., Clark, P. R., Tellides, G., Gerke, V. and Pober, J. S. (2013). Claudin-5 controls intercellular barriers of human dermal microvascular but not human umbilical vein endothelial cells. Arterioscler. Thromb. Vasc. Biol. 33, 489-500.
34. Komarova, Y. and Malik, A. B. (2010). Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu. Rev. Physiol. 72, 463-493.
35. Kowalczyk, A. P. and Nanes, B. A. (2012). Adherens junction turnover: regulating adhesion through cadherin endocytosis, degradation, and recycling. Subcell. Biochem. 60, 197-222.
36. Labauge, P., Denier, C., Bergametti, F. and Tournier-Lasserve, E. (2007). Genetics of cavernous angiomas. Lancet Neurol. 6, 237-244.
37. Lampugnani, M. G., Zanetti, A., Breviario, F., Balconi, G., Orsenigo, F., Corada, M., Spagnuolo, R., Betson, M., Braga, V. and Dejana, E. (2002). VE-cadherin regulates endothelial actin activating Rac and increasing membrane association of Tiam. Mol. Biol. Cell 13, 1175-1189.
38. Lampugnani, M. G., Orsenigo, F., Rudini, N., Maddaluno, L., Boulday, G., Chapon, F. and Dejana, E. (2010). CCM1 regulates vascular-lumen organization by inducing endothelial polarity. J. Cell Sci. 123, 1073-1080.
39. Le Guelte, A., Dwyer, J. and Gavard, J. (2011). Jumping the barrier: VE-cadherin, VEGF and other angiogenic modifiers in cancer. Biol. Cell. 103, 593-605.
40. Liebner, S., Czupalla, C. J. and Wolburg, H. (2011). Current concepts of blood-brain barrier development. Int. J. Dev. Biol. 55, 467-476.
41. McDonald, D. M., Yao, L. C. and Baluk, P. (2011). Dynamics of airway blood vessels and lymphatics: lessons fromdevelopment and inflammation. Proc. Am. Thorac. Soc. 8, 504-507.
42. McDonald, D. A., Shi, C., Shenkar, R., Stockton, R. A., Liu, F., Ginsberg, M. H., Marchuk, D. A. and Awad, I. A. (2012). Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. Stroke 43, 571-574.
43. Nanes, B. A., Chiasson-MacKenzie, C., Lowery, A. M., Ishiyama, N., Faundez, V., Ikura, M., Vincent, P. A. and Kowalczyk, A. P. (2012). p120-catenin binding masks an endocytic signal conserved in classical cadherins. J. Cell Biol. 199, 365-380.
44. Nieset, J. E., Redfield, A. R., Jin, F., Knudsen, K. A., Johnson, K. R. and Wheelock, M. J. (1997).Characterization of the interactions of alpha-catenin with alpha-actinin and beta-catenin/plakoglobin. J. Cell Sci. 110, 1013-1022.
45. Niessen, C. M., Leckband, D. and Yap, A. S. (2011). Tissue organization by cadherin adhesion molecules: dynamic molecular and cellular mechanisms of morphogenetic regulation. Physiol. Rev. 91, 691-731.
46. Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M. and Tsukita, S. (2003). Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 161, 653-660.
47. Noren, N. K., Niessen, C. M., Gumbiner, B. M. and Burridge, K. (2001). Cadherin engagement regulates Rho family GTPases. J. Biol. Chem. 276, 33305-33308.
48. Nourshargh, S., Hordijk, P. L. and Sixt, M. (2010). Breaching multiple barriers: leukocyte motility through venular walls and the interstitium. Nat. Rev. Mol. Cell Biol. 11, 366-378.
49. Orsenigo, F., Giampietro, C., Ferrari, A., Corada, M., Galaup, A., Sigismund, S., Ristagno, G., Maddaluno, L., Young Koh, G., Franco, D. et al. (2012).Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat. Commun. 3, 1208.
50. Pannekoek, W. J., van Dijk, J. J., Chan, O. Y., Huveneers, S., Linnemann, J. R., Spanjaard, E., Brouwer, P. M., van der Meer, A. J., Zwartkruis, F. J., Rehmann, H. et al. (2011). Epac1 and PDZ-GEF cooperate in Rap1 mediated endothelial junction control. Cell. Signal. 23, 2056-2064.
51. Paolinelli, R., Corada, M., Orsenigo, F. and Dejana, E. (2011). The molecular basis of the blood brain barrier differentiation and maintenance. Is it still a mystery? Pharmacol. Res. 63, 165-171.
52. Potente, M., Gerhardt, H. and Carmeliet, P. (2011). Basic and therapeutic aspects of angiogenesis. Cell 146, 873-887.
53. Potter, M. D., Barbero, S. and Cheresh, D. A. (2005). Tyrosine phosphorylation of VE-cadherin prevents binding of p120-and beta-catenin and maintains the cellular mesenchymal state. J. Biol. Chem. 280, 31906-31912.
54. Riant, F., Bergametti, F., Ayrignac, X., Boulday, G. and Tournier-Lasserve, E. (2010). Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. FEBS J. 277, 1070-1075.
55. Richardson, B. T., Dibble, C. F., Borikova, A. L. and Johnson, G. L. (2013). Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling. Biol. Chem. 394, 35-42.
56. Rikitake, Y., Mandai, K. and Takai, Y. (2012). The role of nectins in different types of cell-cell adhesion. J. Cell Sci. 125, 3713-3722.
57. Saito, M., Tucker, D. K., Kohlhorst, D., Niessen, C. M. and Kowalczyk, A. P. (2012). Classical and desmosomal cadherins at a glance. J. Cell Sci. 125, 2547-2552.
58. Sakurai, A., Fukuhara, S., Yamagishi, A., Sako, K., Kamioka, Y., Masuda, M., Nakaoka, Y. and Mochizuki, N. (2006). MAGI-1 is required for Rap1 activation upon cell-cell contact and for enhancement of vascular endothelial cadherin-mediated cell adhesion. Mol. Biol. Cell 17, 966-976.
59. Shapiro, L., Fannon, A. M., Kwong, P. D., Thompson, A., Lehmann, M. S., Grübel, G., Legrand, J. F., Als-Nielsen, J., Colman, D. R. and Hendrickson, W. A. (1995). Structural basis of cell-cell adhesion by cadherins. Nature 374, 327-337.
60. Stockton, R. A., Schaefer, E. and Schwartz, M. A. (2004). p21-activated kinase regulates endothelial permeability through modulation of contractility. J. Biol. Chem. 279, 46621-46630.
61. Stockton, R. A., Shenkar, R., Awad, I. A. and Ginsberg, M. H. (2010). Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J. Exp. Med. 207, 881-896.
62. Sui, X. F., Kiser, T. D., Hyun, S. W., Angelini, D. J., Del Vecchio, R. L., Young, B. A., Hasday, J. D., Romer, L. H., Passaniti, A., Tonks, N. K. et al. (2005). Receptor protein tyrosine phosphatase micro regulates the paracellular pathway in human lung microvascular endothelia. Am. J. Pathol. 166, 1247-1258.
63. Turowski, P., Martinelli, R., Crawford, R., Wateridge, D., Papageorgiou, A. P., Lampugnani, M. G., Gamp, A. C., Vestweber, D., Adamson, P., Dejana, E. et al. (2008). Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration. J. Cell Sci. 121, 29-37.
64. Tzima, E., Irani-Tehrani, M., Kiosses, W. B., Dejana, E., Schultz, D. A., Engelhardt, B., Cao, G., DeLisser, H. and Schwartz, M. A. (2005). A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 437, 426-431.
65. Vestweber, D., Winderlich, M., Cagna, G. and Nottebaum, A. F. (2009). Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol. 19, 8-15.
66. Vestweber, D., Broermann, A. and Schulte, D. (2010). Control of endothelial barrier function by regulating vascular endothelial-cadherin. Curr. Opin. Hematol. 17, 230-236.
67. Weis, S., Shintani, S., Weber, A., Kirchmair, R., Wood, M., Cravens, A., McSharry, H., Iwakura, A., Yoon, Y. S., Himes, N. et al. (2004). Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J. Clin. Invest. 113, 885-894.
68. Weiss, E. E., Kroemker, M., Rüdiger, A. H., Jockusch, B. M. and Rüdiger, M. (1998). Vinculin is part of the cadherin-catenin junctional complex: complex formation between alpha-catenin and vinculin. J. Cell Biol. 141, 755-764.
69. Whitehead, K. J., Chan, A. C., Navankasattusas, S., Koh, W., London, N. R., Ling, J., Mayo, A. H., Drakos, S. G., Jones, C. A., Zhu, W. et al. (2009). The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat. Med. 15, 177-184.
70. Yao, L. C., Baluk, P., Srinivasan, R. S., Oliver, G. and McDonald, D. M. (2012). Plasticity of button-like junctions in the endothelium of airway lymphatics in development and inflammation. Am. J. Pathol. 180, 2561-2575.
71. Zawistowski, J. S., Stalheim, L., Uhlik, M. T., Abell, A. N., Ancrile, B. B., Johnson, G. L. and Marchuk, D. A. (2005). CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum. Mol. Genet. 14, 2521-2531.
72. Zhu, W., London, N. R., Gibson, C. C., Davis, C. T., Tong, Z., Sorensen, L. K., Shi, D. S., Guo, J., Smith, M. C., Grossmann, A. H. et al. (2012). Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability. Nature 492, 252-255.